MedTrace Logo

Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome

NCT02614963 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2016-05-17

No results posted yet for this study

Summary

Clostridium Butyricum might be an effective drug in treating irritable bowel syndrome

Conditions

  • Effect of Clostridium Butyricum in Treating Irritable Bowel Syndrome

Interventions

DRUG

Clostridium Butyricum

Irritable bowel syndrome patients treated with Clostridium Butyricum

DRUG

placebo

Irritable bowel syndrome patients treated with placebo

Sponsors & Collaborators

  • Linyi People's Hospital

    collaborator OTHER

  • Taian City Central Hospital

    collaborator OTHER

  • Qingdao Eastsea Pharmaceutical Co., Ltd.

    collaborator INDUSTRY

  • Shandong University

    lead OTHER

Principal Investigators

  • Li Yanqing, MD,PhD · Qilu Hospital, Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02614963 on ClinicalTrials.gov